AIM IMMUNOTECH INC.
Loading stock data...
Key Financial Metrics (TTM | FY 2024)
$112.00K
Revenue
$-15.75M
Net Income
-2.26
EPS (Diluted)
$-19.18M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-13006.25%
Net Profit Margin
-14062.50%
EBITDA
$-14.57M
Returns & Efficiency
Return on Assets (ROA)
-286.68%
Return on Equity (ROE)
-
Gross Profit
-
Operating Income
$-14.57M
Financial Health
Total Assets
$5.49M
Total Debt
-
Debt to Equity
-x
Current Ratio
0.64
Debt Analysis
Debt to EBITDA
-
Debt to Free Cash Flow
-
Cash & Equivalents
-
Net Debt
-
Capital Returns
Return on Invested Capital (ROIC)
-
Invested Capital
-
Stockholders Equity
-
Revenue Growth
-
Market Valuation
Market Cap
-
P/E Ratio
-
Price to Book
-
EPS (Diluted)
$-2.26
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Insider Transactions
Neutral
Open Market Buys: -
Open Market Sales: -
Option Exercise & Sale: -
Net: -
Loading...
Loading insider transactions...
My Notes & Files
Personal Notes
Attached Files
Loading...
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address |
2117 SW HIGHWAY 484
OCALA, FL 32801 |
| Phone | 352-448-7797 |
| Incorporated | DE, US |
| EIN | 520845822 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 2.09M |
| Stockholders' Equity | $-6.08M |
| Cash & Equivalents | $2.35M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-10
Local
424B3
Prospectus (Rule 424b3)
Prospectus filed under Rule 424(b)(3)
Filed: 2026-02-27
Local
424B4
Prospectus (Rule 424b4)
Prospectus filed under Rule 424(b)(4)
Filed: 2026-02-17
Local
EFFECT
Effectiveness Notice
Notice of effectiveness
Filed: 2026-02-10
Local
S-1/A
Amended IPO Registration
Amendment to IPO registration statement
Filed: 2026-02-10
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-06
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-02-05
Local
S-1/A
Amended IPO Registration
Amendment to IPO registration statement
Filed: 2026-01-23
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-01-20
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-11-17
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-10-29
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-08-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2025-05-15
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2025-04-02
Local
Financial Statistics
Valuation
Market Cap
-
P/E Ratio (TTM)
-
Price to Book
-
EV/Revenue
-
EV/EBITDA
-
Profitability
Gross Margin
-
Operating Margin
-13006.2%
Net Margin
-14062.5%
ROE
-
ROA
-286.7%
Leverage & Liquidity
Debt to Equity
-
Current Ratio
0.64
Total Debt
-
Total Assets
$5.49M
Stockholders' Equity
$-6.08M
Income Statement (FY 2024)
Revenue
$112.00K
Gross Profit
-
Operating Income
$-14.57M
Net Income
$-15.75M
EPS (Diluted)
$-2.26
Cash Flow (FY 2024)
Free Cash Flow
$-19.18M
Cash & Equivalents
$2.35M
Revenue Growth
-34.1%
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...